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Abstract
A simple and sensitive capillary electrophoresis method with solid phase extraction was
developed for the determination of sarafloxacin, ciprofloxacin, enrofloxacin and flumequine
in milk. Solid-phase extraction with Oasis HLB cartridge column was used for the isolation of
four fluoroquinolones in raw milk from a farm and fresh milk sample. Separation conditions
of CE, including running buffer, voltage and temperature, were investigated and optimized.
Baseline separation was achieved for the four fluoroquinolones under the developed con-
ditions. Correlation coefficients greater than 0.9998 were obtained for all fluoroquinolones
with a dynamic range from 1 up to 100 mg L-1. The intra-day precision was less than 5%,
and the inter-day precision was less than 6%. The method recoveries of four fluoroquinolones
were in the range of 70.9–90.6%. The detection limits for sarafloxacin, ciprofloxacin,
enrofloxacin and flumequine was 19.8, 15.2, 13.3 and 15.9 lg kg-1, respectively, which








Quinolones are considered the most
important group of synthetic antibacte-
rial drugs, which operate by interfering
with DNA synthesis by inhibiting DNA
gyrase activity and producing bacterial
death [1]. They are widely used in human
as well as in veterinary medicine for the
treatment of pulmonary, urinary and
digestive infections [2]. The wide usage
of antibiotics may be responsible for the
promotion of resistant stains of bacteria,
but the misuse of these medicines and the
residues may be responsible for in-
creased concerns on public health, for
example, allergic reactions, antibiotic
resistance [3]. Owing to their potential
impact on human health, the European
Union has adopted a maximum residue
level (MRL, 100 lg kg-1) for enroﬂox-
acin and its metabolite ciproﬂoxacin in
milk, however, the tolerance limits for
saraﬂoxacin and ﬂumequine in milk has
not yet been established by the EU [4].
Some ﬂuoroquinolones have been ban-
ned to be used for dairy cows. Therefore,
there is a need for the development of a
simple and selective method for moni-
toring their residue levels in edible ani-
mal products.
Several analytical techniques have
been used for the determination of
quinolone residues. Schenck and Callery
[5] reviewed the developments in the
chromatographic determination of anti-
biotic residues in milk. Carlucci [6] re-
viewed the analysis of biological ﬂuids
for quinolones by liquid chromatogra-
phy (LC). Recently, Andreu et al. [7]
reviewed the analytical strategies to
determine quinolone residues in food
and environmental samples. Among
them, LC is generally used to determine
quinolone residues in biological ﬂuid
and animal tissues. Simultaneous deter-
mination of enroﬂoxacin and its primary
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metabolite ciproﬂoxacin in bovine milk
and plasma by ion-pairing LC with a
detection limit of 5 lg L-1[8] and enro-
ﬂoxacin and its metabolite ciproﬂoxacin
in goat milk by LC using diode-array
detection with the quantiﬁcation limit of
20 lg kg-1 for both analytes [9].
Chromatographic determination of
ﬂumequine in food samples including
milk samples by post-column derivati-
sation with terbium(III) was described
[10]. A column-switching LC ﬂuores-
cence detection method was reported
for the determination and on-line clean-
up of enroﬂoxacin, ciproﬂoxacin, sara-
ﬂoxacin, oxolinic acid, and ﬂumequine
in bovine milk [11]. Recently, liquid
chromatography-tandem mass spec-
trometry (LC-MS-MS) was developed
for monitoring quinolone residues in
bovine milk with quantiﬁcation limits of
0.3–1.5 lg L-1 [12].
Capillary electrophoresis has the
advantage of high separation eﬃciency,
short analysis time, low sample and sol-
vent consumption, low cost of the run-
ning and lower matrix eﬀect compared to
other separation techniques. In addition,
CE can separate compounds in highly
polar and water soluble matrices that
have been traditionally diﬃcult to handle
by chromatographic techniques, for
example highly polar and water soluble
substances [13]. The major drawbacks in
CE are the lower sensitivity and lower
repeatability of the identiﬁcation param-
eter (migration time) in comparison to
the chromatographic techniques. Analy-
sis of antibiotics in biological samples by
CE has been reviewed in 2003 [14]. To
increase the selectivity and sensitivity of
CE, solid phase extraction (SPE) has
been combined with CE for the determi-
nation of ﬂuoroquinolones in plasma
samples with detection limits of
2.2 mg L-1 for ciproﬂoxacin and
1.6 mg L-1 for ﬂumequine [15], cipro-
ﬂoxacin and its impurities with the
detection limit of 1 mg L-1 [16], ﬂumeq-
uine and oxolinic acid in chicken tissues
with detection and quantiﬁcation limits
of 10 and 30 lg kg-1 for ﬂumequine [17],
ciproﬂoxacin, enroﬂoxacin and ﬂumequ-
ine in pig plasma samples with the
detection limits of 70, 85 and 50 lg L-1,
respectively [18], and quinolones residues
in porcine tissue with the detection limit
of 40 lg kg-1 for ciproﬂoxacin and
35 lg kg-1 for enroﬂoxacin [19]. How-
ever there are only few reports of SPE–
CE for the detection of quinolone
residues in milk samples [20]. A novel
analytical method based on capillary
zone electrophoresis-MS-MS was pro-
posed for the identiﬁcation and simulta-
neous quantiﬁcation of eight quinolones
in bovine raw milk with limits of detec-
tion and quantiﬁcation below 6 and 24 lg
L-1, respectively [20]. This method has
low detection limits, but requires an
expensive instrument.
The purpose of this work is to de-
velop a simple and sensitive method for
the determination of four ﬂuoroquino-
lones in milk by CE combined with SPE.
Baseline separation was achieved for the
four ﬂuoroquinolones under the devel-
oped conditions and the recoveries are in
the range of 70.9–90.6%. The intra-day
precision is less than 5%, and the inter-
day precision is less than 6%. The pro-
posed method has high resolution, speed
requires only an extremely small sample
volume. It can be used to conﬁrm the
presence of the four interested ﬂuoro-




All experiments were performed with an
Agilent 3D CE system with air-cooling
and a diode-array detector (Agilent,
Waldbronn, Germany). Data were col-
lected with the Agilent Chemstation
version A.10.02 chromatographic data
system. A 60.9 cm (52.4 cm to the
detector) 9 50 lm I.D. uncoated fused-
silica capillary (Yongnian Optical Fabric
Factory, Handan, China) was utilized.
Centrifuge (Beijing Jingli Centrifuge Co.,
Beijing, China), homogenizer (Hengao
Instrument Co., Tianjin, China), ultra-
sonic cleaner (Ultrasonic Instrument
Co., Kunshan, China) and PHS-3C pH
meter (Shanghai Precision & Scientiﬁc
Instrument Co., Shanghai, China) were
used in sample treatment. Oasis HLB
cartridge column (6 mL, 500 mg) from
Waters Corporation (Milford, USA)
were used for solid phase extraction.
Material and Reagents




acid disodium salt (Na2EDTA), diso-
dium hydrogen phosphate dodecahy-
drate (Na2HPO412H2O) and citric acid
monohydrate (C6H8O7H2O) were ob-
tained from Tianjin Chemical Factory
(Tianjin, China).
Saraﬂoxacin, ciproﬂoxacin, enroﬂox-
acin and ﬂumequine standards were ob-
tained from the National Institute for
the Control of Pharmaceutical and Bio-
logical Products (Beijing, China).
Individual stock solution (1 mg mL-1)
of ﬂuoroquinolone was prepared by dis-
solving 10 mg solid in 0.5 mL 0.01 M
NaOH and diluting to 10 mL with double
deionized water, and stored at -4 C.
Standard solutions of 1, 2, 5, 10, 20, 50 and
100 lg mL-1 were prepared by diluting
the stock solution just before use. Double
deionizedwater was used throughout. The
suspensions were ﬁltered through a mixed
cellulose ester membrane (0.22 lm, Xinya
Puriﬁcation Material Factory, Shanghai,
China).
McIlvane buﬀer containing EDTA
was prepared by adding 21.5 g of diso-
dium hydrogen phosphate dihydrate,
18.6 g of EDTA and 16.8 g of citric acid
monohydrate in 1 L water. The phos-
phate running buﬀer was prepared by
adding 40 mM sodium tetraborate
decahydrate, 42 mM boric acid and
28 mM sodium dihydrogenphosphate in
1 L water. The pH of theMcIlvane buﬀer
containing EDTA and the running buﬀer
was adjusted to 4.0 and 9.2, respectively,
using 1.0 M phosphoric acid or 1.0 M
sodium hydroxide.
Solid Phase Extraction
McIlvane buﬀer containing EDTA (pH
4.0) was used for the precipitation of
protein and extraction of ﬂuoquinolones
from raw milk and fresh milk samples.
Five grams of milk were accurately
weighed and placed in a 100 mL poly-
propylene centrifuge tubes. The milk and
McIlvane buﬀer was mixed with a
mechanical shaker. After shaking for
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2 min the mixture was centrifuged at
4,000 rpm for 20 min. The supernatant
was then passed through an Oasis HLB
cartridge, which was pre-conditioned
with 6 mL methanol and 10 mL water.
After rinsing with 8 mL water, the ﬂuo-
roquinolones were eluted with 6 mL
MeOH. The collected eluate was evapo-
rated to dryness at 50 C under a stream
of nitrogen, and the residue was re-sus-
pended in 1 mL of 0.01 mol L-1 NaOH
and analyzed by CE system.
Electrophoresis Conditions
At the beginning of each day, the capil-
lary was conditioned with 0.1 mol L-1
NaOH for 5 min, followed by water for
8 min and running buﬀer for 10 min. In
order to equilibrate the capillary and
minimize hysteresis eﬀects, the capillary
was ﬂushed with running buﬀer for
4 min between analyses. The phosphate
running buﬀer (pH 9.2) was used for
separation of the four ﬂuoroquinolones,
which was refreshed after six analyses.
Sample introduction was made at the
positive side using the pressure of 5 kPa
for 8 s. The high-voltage power supply
was set to 22 kV. Capillary temperature
was kept at 25 C and the compounds
were detected at 275 nm.
Results and Discussion
Effect of Running Buffer
The running buﬀer is an important fac-
tor for the separation of ﬂuoroquino-
lones. The eﬀect of several buﬀers with




the separation of the four analytes were
ﬁrst tried. Among them, the solution of
40 mMNa2B4O7–42 mMH3BO3–28 mM
NaH2PO4 has higher ionic strength than
that of the others. By using this solution as
the running buﬀer, the baseline separation
was observed for the four ﬂuoroquino-
lones, because increasing the ionic strength
of the running electrolyte allowed, via its
charge screening eﬀect, the modulation of
selectivity thus adjusting the resolution of
closely related ﬂuoroquinolones [21].
Therefore, the system was selected as the
running buﬀer for further experiment.
The pK1 values of the analytes con-
nected with dissociation of the carboxylic
group and and pK2 values associated with
the deprotonation at N4 of the piperazine
ring. For saraﬂoxacin, pK1 = 5.62 and
pK2 = 8.18; for ciproﬂoxacin pK1 =
5.86 and pK2 = 8.24; for enroﬂoxacin,
pK1 = 5.88 and pK2 = 7.74; for
ﬂumequine, pK1 = 6.65 [22]. Taking into
considerations the pKa values, the eﬀect
of pH values from 7 to 9.6 on the sepa-
ration of the four ﬂuoroquinolones was
investigated and the above selected sys-
tem as the running buﬀer was further
studied. When the pH value of the run-
ning buﬀer was less than 8.6, the four
ﬂuoroquinolones could not be separated.
The eﬀect of pH values from 8.6 to 9.6 on
the separation is depicted in Fig. 1.
When the pH value of the running
buﬀer was higher than 9.4, ciproﬂoxacin
and enroﬂoxacin could not be separated.
Baseline separation was achieved at pH
9.2 for the four analytes. As seen in
Fig. 1, the migration order is saraﬂoxa-
cin, ciproﬂoxacin, enroﬂoxacin and
ﬂumequine which, in turn, shows a pK1
value from low to high. The phosphate
running buﬀer with a pH value of 9.2
was selected for separation of the four
ﬂuoroquinolones with higher resolution
and without disturbances.
Effect of Separation Voltage
The eﬀect of voltages on the separation
of the four ﬂuoroquinolones (5 mg L-1
for each ﬂuoroquinolone) was investi-
gated. The peaks of saraﬂoxacin and
ciproﬂoxacin could not be separated
completely at 18 kV, and the saraﬂoxa-
cin peak was small. The migration times
of the analytes were shorter with the in-
crease of the voltage, however, a higher
voltage would cause higher current and
lead to more Joule heating, which
Fig. 1. The eﬀect of pH value on the separation of the four ﬂuoroquinolones 5 mg L-1 for each
ﬂuoroquinolone; separation voltage, 22 kV; capillary temperature, 25 C; injection at 5 kPa for
8 s; DAD detection at 275 nm. 1 = saraﬂoxacin, 2 = ciproﬂoxacin, 3 = enroﬂoxacin,
4 = ﬂumequine
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aﬀected the separation of the tested
analytes [19]. When the voltage was set
at 22–30 kV, baseline separation of the
four ﬂuoroquinolones was achieved. As
higher saraﬂoxacin and ciproﬂoxacin
peaks were obtained at 22 kV, a 22 kV
voltage was selected for CE in this work.
Effect of Separation
Temperature
The eﬀect of the capillary temperature
on the separation of ﬂuoroquinolone
(5 mg L-1 for each ﬂuoroquinolone)
was investigated. The migration time
decreased with the increase of capillary
temperature. Under diﬀerent capillary
temperatures, the resolutions are given
in Table 1.
When the temperature was set at
25 C, CE separation has higher resolu-
tions with 2.66 (R1–2), 7.30 (R2–3) and
3.62 (R3–4). Therefore, a column tem-
perature of 25 C was used for optimized
separation and symmetric peaks.
Extraction and Clean-Up
Most reported extraction procedures
were based on the removal of milk pro-
teins with acidic solutions or organic sol-
vents followed by sample enrichment and
clean-up with SPE. Because the milk
matrix contains interferences such as
proteins, lactose, and inorganic ions, the
success of the extraction procedure de-
pended on the eﬀective deprotenization
and washing steps. Dichloromethane has
been used to extract ciproﬂoxacin and
enroﬂoxacin from chicken muscle tissue
samples with reported recoveries of 74
and 54% for enroﬂoxacin and ciproﬂox-
acin, respectively [23]. A two-step
solid-phase extraction procedure was
developed by Lara et al. [20] using Oasis
MAX and HLB cartridges without pro-
tein precipitation. In our previous work,
acetonitrile was used for protein precipi-
tation and extraction of seven quinolones
in porcine tissue [19]. In this work,
McIlvane/EDTA solution (pH 4.0) and
Oasis HLB cartridges were used for the
precipitation of protein and the extrac-
tion of ﬂuoquinolones frommilk samples.
McIlvain buﬀer containing EDTA is a
mild acidic solvent, it helps chelating
metals and prevents them from binding to
the adsorbing sites resulting in extraction
eﬃciency of the analytes to be improved.
Since the ﬂuoroquinolones were sol-
uble in water and dissoluble in organic
solvents, water was used for washing the
SPE material after sample application to
wash oﬀ the solvents and avoid loss of
analytes. Methanol was used as eluting
solvent to improve the recoveries of
these ﬂuoroquinolones.
The eﬀect of diﬀerent eluting volumes
(4, 5, 6, 7, 8 mL) of methanol on recov-
eries was also investigated. The obtained
recoveries were in the range of 60.5–
70.6% for saraﬂoxacin, 66.5–78.4% for
ciproﬂoxacin, 74.5–90.0% for enroﬂoxa-
cin, and 74.8–89.6% for ﬂumequine.With
a selected 6 mL methanol elution, recov-
eries from 70.1 to 90.0% were obtained
for the four ﬂuoroquinolones. Under the
optimal conditions the eﬀective separa-
tion of the four ﬂuoroquinolones in
spiked fresh milk samples without inter-
ference were observed, as shown in Fig. 2.
Validation Results
The linearity of calibration curves was
evaluated with measured peak areas
against concentrations of calibration
standards under the optimal conditions.
The equations of calibration curves ob-
tained based on three replicate measure-
ments of standard solution were as
follows: A = 1.7172C + 0.7522, r =
0.99989 for saraﬂoxacin; A = 2.4033C
+ 0.8112, r = 0.99994 for ciproﬂoxacin;
A = 2.9206C + 0.9624, r = 0.99991 for
enroﬂoxacin; A = 1.9616C + 1.6897,
r = 0.99989 for ﬂumequine. Correlation
coeﬃcients (r) greater than 0.9998 were
obtained for all ﬂuoroquinolones with a
dynamic range from 1 up to 100 lg mL-1.
The limit of detection (LOD) was
determined as the sample concentration
that produces a peak height of three
times the level of the baseline noise. The
limit of quantiﬁcation (LOQ) was de-
ﬁned as the sample concentration that
produced a peak height of ten times the
signal-to-noise ratio [19, 23]. For the
determination of saraﬂoxacin, cipro-
ﬂoxacin, enroﬂoxacin and ﬂumequine
standard solution, LODs are 14.2, 12.0,
12.0 and 14.4 lg L-1, and for the anal-
ysis of the spiked milk sample the LODs
are 19.8,15.2, 13.3 and 15.9 lg kg-1,
respectively, and the LOQs are 66.0,
50.7, 44.3 and 53.2 lg kg-1, respectively,
for the same ﬂuoroquinolones. The
detection limits of the proposed method
were lower than those for LC [9] and CE
[15, 16, 18, 19], and higher or close to
those for LC-MS-MS [12] or SPE-LC-
MS-MS [20]. The obtained detection
limits of the ﬂuoroquinolones studied
permit the detection in milk samples at
the targeted MLRs. The recoveries of the
targeted ﬂuoroquinolones from spiked
raw milk from farms and spiked fresh
milk samples were investigated. The
recovery of the analyte at a spiked level
of 2 mg kg-1 for raw milk samples from
farms was 70.9% for saraﬂoxacin,
78.0% for ciproﬂoxacin, 89.3% for en-
roﬂoxacin and 90% for ﬂumequine, and
the relative standard deviation (RSD)
Fig. 2. Electropherogram of fresh milk sample spiked at 2 mg kg-1 level for each ﬂuoroquin-
olone using phosphate running buﬀer (pH 9.2) and conditions given in Fig. 1. 1 = saraﬂoxacin,
2 = ciproﬂoxacin, 3 = enroﬂoxacin, 4 = ﬂumequine
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was in the range of 1.75–2.23%. For
fresh milk samples, the recoveries are
provided in Table 2, along with the in-
tra- and inter-day precisions RSD.
The method recoveries range from
70.9 to 90.6% for the targeted ﬂuoro-
quinolones with RSDs <2.3%. The
reason(s) for the relatively low recoveries
observed with saraﬂoxacin and cipro-
ﬂoxacin are not known and possibly re-
lated to their molecular structures and
combinative intensity with milk matrix.
The RSD of peak areas was used to
express intra- and inter-day precision. As
shown inTable 2, themilk samples spiked
at the 2 mg kg-1 level of each ﬂuoro-
quinolonewere analyzed in four replicates
on a single day, an intra-day precision
(n = 4) of <5% and an inter-day preci-
sion (n = 6) of <6% were achieved.
Conclusion
This work has shown that McIlvaine
buﬀer containing EDTA (pH 4.0) is an
eﬀective solvent for extracting ﬂuoro-
quinolones in milk samples, methanol is
an eﬃcient solvent for eluting the ana-
lytes from the Oasis HLB cartridges.
Optimal separation was achieved with
the use of the phosphorate running
buﬀer (pH 9.2) as the running buﬀer.
Successful baseline separation and
quantitation of four ﬂuoroquinolones in
milk samples was achieved with the use
of Oasis HLB cartridges as SPE for
interferences—free CE analysis. The
proposed method has the advantages of
short analysis time, simple clean-up sys-
tem, high detection capability, and can
be applied to monitor structurally re-
lated novel ﬂuoroquinolone antibiotics
in milk samples.
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15 1.85 9.45 3.81
20 2.35 6.62 3.65
25 2.66 7.30 3.62
30 2.63 5.49 3.57
a Saraﬂoxacin(1), ciproﬂoxacin(2), enro-
ﬂoxacin(3), and ﬂumequine(4)











Saraﬂoxacin 2 71.6 1.51 4.31 4.46
Ciproﬂoxacin 2 78.3 1.45 4.72 5.37
Enroﬂoxacin 2 90.3 1.53 3.35 4.67
Flumequine 2 90.6 1.32 2.51 3.07
a n = 3
b n = 4
c n = 6
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